1.72 Despite shrinking by US$130m in the past week, Celldex Therapeutics (NASDAQ:CLDX) shareholders are still up 662% over 5 years

News


<< back

Despite shrinking by US$130m in the past week, Celldex Therapeutics (NASDAQ:CLDX) shareholders are still up 662% over 5 years
Date: 2024-01-19 [news.yahoo.com]

READ THE FULL NEWS >>
×